{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:14:36Z","timestamp":1794694476130,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016215","name":"Autonomous University of Chihuahua","doi-asserted-by":"publisher","award":["UACH-24-009"],"award-info":[{"award-number":["UACH-24-009"]}],"id":[{"id":"10.13039\/100016215","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cyto.2025.157031","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T23:12:49Z","timestamp":1758064369000},"page":"157031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["IL-33 links inflammation and bone remodeling in experimental spondyloarthritis and human joint biopsies"],"prefix":"10.1016","volume":"196","author":[{"given":"Susana Aide\u00e9","family":"Gonz\u00e1lez-Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Loya-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Prieto-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Chaparro-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Alberto","family":"Ruizesparza-Hinojos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Pacheco-Tena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2025.157031_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2025.157031_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an Interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.157031_bb0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","article-title":"Interleukin-33 \u2013 cytokine of dual function or novel alarmin?","volume":"30","author":"Haraldsen","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.cyto.2025.157031_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrrheum.2011.53","article-title":"Interleukin-33 biology with potential insights into human diseases","volume":"7","author":"Palmer","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/03009742.2012.735700","article-title":"Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis","volume":"42","author":"Li","year":"2013","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0045","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10067-011-1843-x","article-title":"Serum levels of IL-33 is increased in patients with ankylosing spondylitis","volume":"30","author":"Han","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/reum.2015.50551","article-title":"Cytokine profiles in axial spondyloarthritis","volume":"53","author":"Madej","year":"2015","journal-title":"Reumatologia"},{"key":"10.1016\/j.cyto.2025.157031_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631603","article-title":"IL-33 gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients","volume":"12","author":"Iwaszko","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/03009742.2014.882408","article-title":"Single nucleotide polymorphisms of the interleukin-33 (IL-33) gene are associated with ankylosing spondylitis in Chinese individuals: a case\u2013control pilot study","volume":"43","author":"Fan","year":"2014","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/ard-2022-223791","article-title":"Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis","volume":"82","author":"Tavasolian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157031_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111697","article-title":"Evaluation of interleukins (IL-1\u03b1, IL-1Ra, IL-12, IL-17A, IL-31, and IL-33) and chemokines (CXCL10 and CXCL16) in the serum of male patients with ankylosing spondylitis","volume":"129","author":"Muhsin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2025.157031_bb0075","first-page":"437","article-title":"Bone changes and curative effect of infliximab in patients with ankylosing spondylitis","volume":"20","author":"Li","year":"2020","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.cyto.2025.157031_bb0080","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200164","article-title":"IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors","volume":"217","author":"Swann","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.157031_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s41927-024-00436-0","article-title":"Intermittent fasting reduces inflammation and joint damage in a murine model of rheumatoid arthritis: insights from transcriptomic and metagenomic analyses","volume":"8","author":"Cuevas-Mart\u00ednez","year":"2024","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1480-9222-14-10","article-title":"Spontaneous arthritis and ankylosis in male DBA\/1 mice: further evidence for a role of behavioral factors in \u201cstress-induced arthritis\u201d","volume":"14","author":"Braem","year":"2012","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.cyto.2025.157031_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3899\/jrheum.140218","article-title":"Bone lineage proteins in the entheses of the midfoot in patients with spondyloarthritis","volume":"42","author":"Pacheco-Tena","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.157031_bb0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00011-021-01453-2","article-title":"Stability of housekeeping genes in inflamed joints of spontaneous and collagen-induced arthritis in DBA\/1 mice","volume":"70","author":"Qui\u00f1onez-Flores","year":"2021","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cyto.2025.157031_bb0105","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.7150\/thno.48666","article-title":"Cadherin-11 cooperates with inflammatory factors to promote the migration and invasion of fibroblast-like synoviocytes in pigmented villonodular synovitis","volume":"10","author":"Cao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cyto.2025.157031_bb0110","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/eji.202149263","article-title":"Collagen type VI is the antigen recognized by the ER-TR7 antibody","volume":"51","author":"Schiavinato","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.739489","article-title":"IL-33 in rheumatic diseases","volume":"8","author":"Dong","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.cyto.2025.157031_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/4297354","article-title":"Blocking Interleukin-33 alleviates the joint inflammation and inhibits the development of collagen-induced arthritis in mice","volume":"2020","author":"Li","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cyto.2025.157031_bb0125","article-title":"Blocking IL-33 decelerates cartilage degeneration in knee osteoarthritis through mice model","volume":"19","author":"Wu","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2025.157031_bb0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-024-01618-5","article-title":"Carvone-loaded chitosan nanoparticles alleviate joint destruction by downregulating the expression of pro, inflammatory cytokines and MMP-13 in adjuvant-induced rat model","volume":"33","author":"Kanwal","year":"2025","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.cyto.2025.157031_bb0135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.1780350619","article-title":"Characterization of a spontaneously occurring arthritis in male DBA\/1 mice","volume":"35","author":"Nordling","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157031_bb0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/ard.2003.013599","article-title":"Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA\/1 mice: a model of psoriatic arthritis","volume":"63","author":"Lories","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2025.157031_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cyto.2025.157031_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanh\u00e4usser","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2025.157031_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jbspin.2015.07.008","article-title":"Molecular mechanisms of bone formation in spondyloarthritis","volume":"83","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cyto.2025.157031_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102803","article-title":"Mechanisms of ossification of the entheses in spondyloarthritis physiopathogenic aspects and possible therapeutic implication","volume":"94","author":"Raffaele","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.cyto.2025.157031_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-017-0681-5","article-title":"Mechanism of new bone formation in axial Spondyloarthritis","volume":"19","author":"Poddubnyy","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cyto.2025.157031_bb0170","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","article-title":"Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis","volume":"60","author":"Palmer","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2025.157031_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1187","article-title":"Blockade of IL-33 signalling attenuates osteoarthritis","volume":"9","author":"He","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0180","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s12035-022-02754-1","article-title":"Inhibition of spinal Interleukin-33 attenuates peripheral inflammation and hyperalgesia in experimental arthritis","volume":"59","author":"Huang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cyto.2025.157031_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141330","article-title":"WTAP improves chondrocyte loss and dysfunctions to ameliorate osteoarthritis through mediating the mA methylation and mRNA stability of IL-33","volume":"306","author":"Yang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cyto.2025.157031_bb0190","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s12276-024-01351-7","article-title":"IL33-induced neutrophil extracellular traps (NETs) mediate a positive feedback loop for synovial inflammation and NET amplification in rheumatoid arthritis","volume":"56","author":"Tang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cyto.2025.157031_bb0195","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.7150\/thno.48028","article-title":"IL-33\/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cyto.2025.157031_bb0200","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02231-2024","article-title":"A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4","author":"Singh","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cyto.2025.157031_bb0205","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.2101070","article-title":"The IL-33\/ST2 Axis promotes primary Sj\u00f6gren's syndrome by enhancing salivary epithelial cell activation and type 1 immune response","volume":"208","author":"Dong","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0210","article-title":"Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: a phase 2a randomized controlled trial (FRONTIER \u22122)","author":"Silverberg","year":"2024","journal-title":"Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cyto.2025.157031_bb0215","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2025.157031_bb0220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2025.157031_bb0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2213-2600(21)00556-7","article-title":"Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial","volume":"10","author":"Yousuf","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cyto.2025.157031_bb0230","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jaci.2022.08.015","article-title":"Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis","volume":"150","author":"Maurer","year":"2022","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T09:20:35Z","timestamp":1762593635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S1043466625001784"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157031","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-33 links inflammation and bone remodeling in experimental spondyloarthritis and human joint biopsies","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157031"}}